Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
162M
-
Number of holders
-
200
-
Total 13F shares, excl. options
-
175M
-
Shares change
-
+3.83M
-
Total reported value, excl. options
-
$2.25B
-
Value change
-
+$54.4M
-
Put/Call ratio
-
0.2
-
Number of buys
-
103
-
Number of sells
-
-94
-
Price
-
$12.87
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q2 2021
245 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q2 2021.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 175M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (21.1M shares), BROWN CAPITAL MANAGEMENT LLC (18.5M shares), Sarissa Capital Management LP (16.4M shares), VANGUARD GROUP INC (13.9M shares), BlackRock Inc. (11.6M shares), Camber Capital Management LP (7.5M shares), STATE STREET CORP (6.81M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (6.26M shares), PUTNAM INVESTMENTS LLC (4.74M shares), and LSV ASSET MANAGEMENT (4.36M shares).
This table shows the top 200 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.